- •Foreword I
- •Foreword II
- •Preface
- •Contents
- •1 Abscesses – Pyogenic Type
- •3 Cyst I – Typical Small
- •4 Cyst II – Typical Large with MR-CT Correlation
- •5 Cyst III – Multiple Small Lesions with MR-CT-US Comparison
- •6 Cyst IV – Adult Polycystic Liver Disease
- •7 Cystadenoma / Cystadenocarcinoma
- •8 Hemangioma I – Typical Small
- •10 Hemangioma III – Typical Giant
- •11 Hemangioma IV – Giant Type with a Large Central Scar
- •13 Hemangioma VI – Multiple with Perilesional Enhancement
- •14 Hemorrhage
- •16 Mucinous Metastasis – Mimicking an Hemangioma
- •17 Colorectal Metastases I – Typical Lesion
- •18 Colorectal Metastases II – Typical Multiple Lesions
- •19 Colorectal Metastases III – Metastasis Versus Cyst
- •20 Colorectal Metastases IV – Metastasis Versus Hemangiomas
- •21 Liver Metastases V – Large, Mucinous, Mimicking a Primary Liver Lesion
- •24 Breast Carcinoma Liver Metastases
- •25 Kahler’s Disease (Multiple Myeloma) Liver Metastases
- •26 Melanoma Liver Metastases I – Focal Type
- •27 Melanoma Liver Metastases II – Diffuse Type
- •28 Neuroendocrine Tumor I – Typical Liver Metastases
- •29 Neuroendocrine Tumor II – Pancreas Tumor Metastases
- •30 Neuroendocrine Tumor III – Gastrinoma Liver Metastases
- •31 Neuroendocrine Tumor IV – Carcinoid Tumor Liver Metastases
- •32 Neuroendocrine Tumor V – Peritoneal Spread
- •34 Renal Cell Carcinoma Liver Metastasis
- •35 Cirrhosis I – Liver Morphology
- •36 Cirrhosis II – Regenerative Nodules and Confluent Fibrosis
- •37 Cirrhosis III – Dysplastic Nodules
- •38 Cirrhosis IV – Dysplastic Nodules – HCC Transition
- •39 Cirrhosis V – Cyst in a Cirrhotic Liver
- •40 Cirrhosis VI – Multiple Cysts in a Cirrhotic Liver
- •41 Cirrhosis VII – Hemangioma in a Cirrhotic Liver
- •42 HCC in Cirrhosis I – Typical Small with Pathologic Correlation
- •43 HCC in Cirrhosis II – Small With and Without a Tumor Capsule
- •44 HCC in Cirrhosis III – Nodule-in-Nodule Appearance
- •45 HCC in Cirrhosis IV – Mosaic Pattern with Pathologic Correlation
- •47 HCC in Cirrhosis VI – Mosaic Pattern with Fatty Infiltration
- •48 HCC in Cirrhosis VII – Large Growing Lesion with Portal Invasion
- •49 HCC in Cirrhosis VIII – Segmental Diffuse with Portal Vein Thrombosis
- •50 HCC in Cirrhosis IX – Multiple Lesions Growing on Follow-up
- •51 HCC in Cirrhosis X – Capsular Retraction and Suspected Diaphragm Invasion
- •52 HCC in Cirrhosis XI – Diffuse Within the Entire Liver with Portal Vein Thrombosis
- •53 HCC in Cirrhosis XII – With Intrahepatic Bile Duct Dilatation
- •54 Focal Nodular Hyperplasia I – Typical with Large Central Scar and Septa
- •55 Focal Nodular Hyperplasia II – Typical with Pathologic Correlation
- •57 Focal Nodular Hyperplasia IV – Multiple FNH Syndrome
- •58 Focal Nodular Hyperplasia V – Fatty FNH with Concurrent Fatty Adenoma
- •59 Focal Nodular Hyperplasia VI – Atypical with T2 Dark Central Scar
- •60 Hepatic Angiomyolipoma – MR-CT Comparison
- •61 Hepatic Lipoma – MR-CT-US Comparison
- •62 Hepatocellular Adenoma I – Typical with Pathologic Correlation
- •63 Hepatocellular Adenoma II – Large Exophytic with Pathologic Correlation
- •64 Hepatocellular Adenoma III – Typical Fat-Containing
- •65 Hepatocellular Adenoma IV – With Large Hemorrhage
- •77 Intrahepatic Cholangiocarcinoma – With Pathologic Correlation
- •78 Telangiectatic Hepatocellular Lesion
- •79 Focal Fatty Infiltration Mimicking Metastases
- •80 Focal Fatty Sparing Mimicking Liver Lesions
- •81 Hemosiderosis – Iron Deposition, Acquired Type
- •82 Hemochromatosis – Severe Type
- •83 Hemochromatosis with Solitary HCC
- •84 Hemochromatosis with Multiple HCC
- •85 Thalassemia with Iron Deposition
- •86 Arterioportal Shunt I – Early Enhancing Lesion in a Cirrhotic Liver
- •89 Budd-Chiari Syndrome II – Gradual Deformation of the Liver
- •90 Budd-Chiari Syndrome III – Nodules Mimicking Malignancy
- •92 Caroli’s Disease I – Intrahepatic with Segmental Changes
- •93 Caroli’s Disease II – Involvement of the Liver and Kidneys
- •95 Choledocholithiasis (Bile Duct Stones)
- •96 Gallbladder Carcinoma I – Versus Gallbladder Wall Edema
- •97 Gallbladder Carcinoma II – Hepatoid Type of Adenocarcinoma
- •98 Hilar Cholangiocarcinoma I – Typical
- •99 Hilar Cholangiocarcinoma II – Intrahepatic Mass
- •100 Hilar Cholangiocarcinoma III – Partially Extrahepatic Tumor
- •101 Hilar Cholangiocarcinoma IV – Metal Stent with Interval Growth
- •102 Hilar Cholangiocarcinoma V – Biliary Dilatation Mimicking Klatskin Tumor at CT
- •103 Primary Sclerosing Cholangitis I – Cholangitis and Segmental Atrophy
- •104 Primary Sclerosing Cholangitis II – With Intrahepatic Cholestasis
- •105 Primary Sclerosing Cholangitis III – With Intrahepatic Stones
- •106 Primary Sclerosing Cholangitis IV – With Biliary Cirrhosis
- •107 Primary Sclerosing Cholangitis V – With Intrahepatic Cholangiocarcinoma
- •108 Primary Sclerosing Cholangitis VI – With Hilar Cholangiocarcinoma
- •109 T2 Bright Liver Lesions
- •110 T1 Bright Liver Lesions
- •111 T2 Bright Central Scar
- •112 Lesions in Fatty Liver
- •113 Appendix I: MR Imaging Technique and Protocol
- •114 Appendix II: Liver Segmental and Vascular Anatomy
- •Subject Index
180 Part III – Diffuse (Depositional) Liver Diseases
85 Thalassemia with Iron Deposition
Thalassemia major is one of the most prevalent diseases caused by an abnormality in a single gene (monogenic), which results in defects in hemoglobin production of alphaor beta-chain and affects multiple organs. The worldwide birth rate of symptomatic globin disorders, including thalassemias, is no less than 240 per 100,000 births, of which 196 have sickle cell disease and 44 have thalassemias. Currently, over 2 million patients are transfusion-dependent worldwide, with the majority in Southeast Asia. Children with thalassemia usually become symptomatic between 6 and 12 months of age with symptoms of anemia and enlargement of the liver and spleen due to extramedullary hematopoiesis. Without iron chelation, iron-mediated free radical damage may cause hemosiderosis with liver fibrosis, myocardial damage with cardiac hypertrophy and dilatation (cardiomyopathy), skin pigmentation and endocrine failure including (bronze) diabetes mellitus, growth failure and delayed onset of puberty.
Literature
1.Tyler PA, Madani G, Chaudhuri R, et al. (2006) The radiological appearances of thalassemia. Clin Radiol 61:40 – 52
2.Mazza P, Giua R, De Marco S, et al. (1995) Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Haematologica 80:398 – 404
3.Papakonstantinou O, Kostaridou S, Maris T, et al. (1999) Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. J Pediatr Hematol Oncol 21:142 – 148
4.Rund D, Rachmilewitz E (2005) Beta-thalassemia. NEJM 353:1135 – 1146
MR Imaging Findings
In thalassemia, as a result of blood transfusions, excessive iron deposition within Kupffer cells (hemosiderosis) may lead to secondary hemochromatosis (parenchymal) iron overload. Parenchymal iron deposition may also result from associated genetic hemochromatosis. At MR imaging signal loss may be observed both in organs with Kupffer cell (liver, spleen, bone marrow) and in parenchymal (pancreas and myocardium) compartments (Figs. 85.1 – 85.3).
Management
Management of the resulting anemia is through blood transfusions. Repeated transfusions result in excessive iron overload, removal of which is achieved through iron chelation therapy. Without blood transfusion, patients may develop massive bone marrow or extramedullary hematopoiesis, resulting in deformities of the facial bones, spinal cord compression and pathologic fractures. Desferrioxamine is the most widely used iron chelator.
85 Thalassemia with Iron Deposition 181
Fig. 85.1. Thalassemia with severe iron deposition. T1 TE = 2.3 ms: liver, pancreas (solid arrow) and lymph nodes (open arrow) have abnormally low signal intensity; T1 TE = 4.6 ms: note the loss of signal in the previously men-
Fig. 85.2. Thalassemia with parenchymal and Kupffer cell iron deposition, severe, MRI findings. A Axial T1 with the short TE (T1 TE = 2.3 ms): The liver, pancreas (solid arrow), and lymph nodes (open arrow) are much darker than the muscle due to parenchymal and Kupffer cell iron deposition. B Axial T1 GRE with a longer TE (T1 TE = 4.6 ms): Also one of the vertebrae is darkened indicating involvement. C Axial T1 GRE with a longer TE (T1 TE =
tioned structures as well as in one of the vertebrae; T1 TE = 12 ms: there is further loss of signal; ART: the liver appears less dark (TE of this sequence is set to a minimum of about 1.2 ms) (patient had undergone splenectomy)
12 ms) shows further decrease in signal. D Axial arterial image (ART): No enhancing nodules are present. E Coronal SSTSE image (SSTSE): The liver is as dark as the lung (*). F Coronal SSTSE image (SSTSE): The vertebra (*) is as dark as the lung. G and H Axial T1 with respectively the short (2.3 ms) and long TEs (4.6 ms) at the level of the heart: The myocardium shows loss of signal due to iron deposition (arrows)
Fig. 85.3. Various compartments with iron deposition. A Legend to the following two drawings. B The drawing shows the myocardium (parenchymal) and the vertebra (Kupffer cells) compartments. C The drawing shows the liver (parenchyma as well as Kupffer cells), the vertebra, the lymph nodes, and
the spleen (Kupffer cells), and the pancreas (parenchymal) compartments. D Photomicrograph of a different patient shows the parenchymal iron deposition in the liver. Iron Perls’, × 100
Part IV
Vascular Liver Lesions |
IV |